Ruxolitinib cream for vitiligo on face and neck
Part of Skin clinical trials.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have stable vitiligo on your face and neck, covering at least 0.5% of your body surface area.
- You have used tacrolimus cream on your face and neck for at least 3 months without much improvement.
- You agree to stop using other treatments on your face and neck during the study.
- If you can become pregnant or father a child, you must use effective birth control during the study.
- You are willing to follow the study rules and give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
This study tests whether a cream called ruxolitinib can help restore skin color in children ages 2–11 with vitiligo, a condition causing white patches on the skin. The cream works by reducing inflammation that stops the body from making skin pigment.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.